JP2019518798A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019518798A5 JP2019518798A5 JP2019519626A JP2019519626A JP2019518798A5 JP 2019518798 A5 JP2019518798 A5 JP 2019518798A5 JP 2019519626 A JP2019519626 A JP 2019519626A JP 2019519626 A JP2019519626 A JP 2019519626A JP 2019518798 A5 JP2019518798 A5 JP 2019518798A5
- Authority
- JP
- Japan
- Prior art keywords
- cdp
- pharmaceutical composition
- composition according
- dag
- choline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662355096P | 2016-06-27 | 2016-06-27 | |
| US62/355,096 | 2016-06-27 | ||
| PCT/US2017/039545 WO2018005527A1 (en) | 2016-06-27 | 2017-06-27 | Liponucleotide-based therapy for ards |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019518798A JP2019518798A (ja) | 2019-07-04 |
| JP2019518798A5 true JP2019518798A5 (enExample) | 2020-08-06 |
Family
ID=60786443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019519626A Pending JP2019518798A (ja) | 2016-06-27 | 2017-06-27 | リポヌクレオチドに基づくａｒｄｓの治療 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10874684B2 (enExample) |
| EP (2) | EP4292651A3 (enExample) |
| JP (1) | JP2019518798A (enExample) |
| KR (1) | KR20190022682A (enExample) |
| CN (1) | CN109475554A (enExample) |
| AU (1) | AU2017289278A1 (enExample) |
| CA (1) | CA3029005A1 (enExample) |
| SG (1) | SG11201811595SA (enExample) |
| WO (1) | WO2018005527A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3029005A1 (en) * | 2016-06-27 | 2018-01-04 | Ohio State Innovation Foundation | Liponucleotide-based therapy for ards |
| WO2019005898A1 (en) | 2017-06-27 | 2019-01-03 | Ohio State Innovation Foundation | LIPONUCLEOTID THERAPY FOR COPD |
| EP4125857A4 (en) * | 2020-03-31 | 2024-04-17 | Diffusion Pharmaceuticals LLC | USE OF DIFFUSION ENHANCEMENT COMPOUNDS FOR THE TREATMENT OF RESPIRATORY DISEASE INDUCED BY VIRUSES AND BACTERIA |
| US12440464B2 (en) | 2020-05-01 | 2025-10-14 | Irazu Bio | Method for treating respiratory viral infections comprising administration of fatty acid compositions |
| WO2023173043A1 (en) * | 2022-03-11 | 2023-09-14 | Arizona Board Of Regents On Behalf Of Arizona State University | Pegylated serp-1 protein treatment improves outcomes after sars-cov-2 infection |
| WO2023177995A2 (en) * | 2022-03-18 | 2023-09-21 | Ohio State Innovation Foundation | Cdp-choline a host-directed therapeutic for disease caused by sars cov-2 infection |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4386078A (en) * | 1980-03-03 | 1983-05-31 | The Ohio State University Research Foundation | Therapeutic agents for preventing phospholipid degradation and free fatty acid proliferation |
| DE3883374T2 (de) * | 1987-10-28 | 1993-12-09 | Pro Neuron Inc | Acylatiertes uridin und cytidin und deren verwendungen. |
| US5470838A (en) * | 1987-10-28 | 1995-11-28 | Pro-Neuron, Inc. | Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine |
| WO1996001115A1 (en) * | 1994-07-01 | 1996-01-18 | Pro-Neuron, Inc. | Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| US6825174B2 (en) * | 1995-06-07 | 2004-11-30 | East Carolina University | Composition, formulations & method for prevention & treatment of diseases and conditions associated with bronchoconstriction, allergy(ies) & inflammation |
| US20030181353A1 (en) * | 1998-08-03 | 2003-09-25 | Nyce Jonathan W. | Composition & use as analgesic, anti-inflammatory, wound healing agent, for treatment of heart conditions, assessment of heart function & tissue & cell protection & healing & reperfusion, mood disorders & symptoms & sequelae of menopause & for inducing unconsciousness, sleep & anesthesia |
| US20040049022A1 (en) * | 2001-04-24 | 2004-03-11 | Nyce Jonathan W. | Composition & methods for treatment and screening |
| US20040063674A1 (en) * | 2001-07-13 | 2004-04-01 | Levy Stuart B. | Tetracycline compounds having target therapeutic activities |
| WO2003043613A2 (en) * | 2001-11-21 | 2003-05-30 | Danmarks Jordbrugsforskning | Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| CN101175499B (zh) * | 2004-11-17 | 2010-12-22 | 耶路撒冷希伯来大学依苏姆研究发展公司 | 脂质结合物在制备治疗疾病药物中的用途 |
| US10086009B2 (en) * | 2005-05-23 | 2018-10-02 | Massachusetts Institute Of Technologies | Compositions containing pufa and/or uridine and methods of use thereof |
| CN101506218A (zh) * | 2005-05-23 | 2009-08-12 | 麻省理工学院 | 含有多不饱和脂肪酸的组合物及其使用方法 |
| CA3029005A1 (en) * | 2016-06-27 | 2018-01-04 | Ohio State Innovation Foundation | Liponucleotide-based therapy for ards |
| WO2019005898A1 (en) * | 2017-06-27 | 2019-01-03 | Ohio State Innovation Foundation | LIPONUCLEOTID THERAPY FOR COPD |
| US11850283B2 (en) * | 2017-06-27 | 2023-12-26 | Ohio State Innovation Foundation | Liponucleotide-based therapy for asthma |
-
2017
- 2017-06-27 CA CA3029005A patent/CA3029005A1/en active Pending
- 2017-06-27 JP JP2019519626A patent/JP2019518798A/ja active Pending
- 2017-06-27 EP EP23207788.3A patent/EP4292651A3/en active Pending
- 2017-06-27 WO PCT/US2017/039545 patent/WO2018005527A1/en not_active Ceased
- 2017-06-27 EP EP17821089.4A patent/EP3474853A4/en not_active Withdrawn
- 2017-06-27 SG SG11201811595SA patent/SG11201811595SA/en unknown
- 2017-06-27 AU AU2017289278A patent/AU2017289278A1/en not_active Abandoned
- 2017-06-27 CN CN201780039385.4A patent/CN109475554A/zh active Pending
- 2017-06-27 KR KR1020197002042A patent/KR20190022682A/ko not_active Ceased
-
2018
- 2018-12-21 US US16/230,225 patent/US10874684B2/en active Active
-
2020
- 2020-11-19 US US16/952,557 patent/US20210069225A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019518798A5 (enExample) | ||
| JP2013518107A5 (enExample) | ||
| BR112020018209A2 (pt) | Composições farmacêuticas, recipiente pressurizado, e, métodos para tratar ou prevenir uma infecção viral e para tratar ou prevenir um coronavírus humano, coronavírus sars, coronavírus mers, vírus da encefalite equina oriental, vírus da encefalite equina ocidental, vírus da encefalite equina venezuelana, vírus da chicungunha, vírus ross river, rsv, vírus influenza a, vírus influenza b, vírus tacaribe, vírus pichinde, vírus junin, vírus da febre lassa, vírus da cariomeningite linfocitária, vírus da febre rift valley, vírus punta toro, vírus lacrosse, vírus maporal, vírus heartland, e vírus da síndrome de trombocitopenia de febre severa, poliovírus, vírus de coxsackie, infecção de norovírus ou enterovírus em um paciente | |
| EP3356355B1 (en) | Compounds and combinations for the treatment of hiv | |
| TR201906470T4 (tr) | İmmünomodülatörler. | |
| Murugan et al. | COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks | |
| US10874684B2 (en) | Liponucleotide-based therapy for ARDS | |
| JP2010270130A5 (enExample) | ||
| MX2014009546A (es) | Compuestos antivirales con una porcion heterotriciclica. | |
| WO2021211885A8 (en) | Matrix bound vesicles (mbv) for treatment of acute respiratory distress syndrome | |
| CA3153281A1 (en) | 4'-halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto | |
| JP2013542196A5 (enExample) | ||
| RU2747467C1 (ru) | Способ защиты от коронавирусной инфекции | |
| RU2012116226A (ru) | Бронхолитическое средство на основе простагландина | |
| WO2015127714A1 (zh) | 黄芩苷在制备治疗蓖麻毒素中毒药物中的应用 | |
| RU2609857C1 (ru) | Использование композиции, состоящей из катионного пептида LTP и молекул РНК против респираторных вирусов | |
| JP2011006424A5 (enExample) | ||
| JP7786743B2 (ja) | ４’－ハロゲン含有ヌクレオチドおよびヌクレオシド治療組成物ならびにそれらに関連する使用 | |
| Wang et al. | Discovery and Development of VV116: A Novel Oral Nucleoside Anti‐SARS‐CoV‐2 Drug | |
| JP2011016804A5 (enExample) | ||
| JP2020521838A5 (enExample) | ||
| ZAREMBA et al. | TOXICITY OF POLYHYDRATED FULLERENES WITH ANTI-INFLUENZA ACTIVITY IN BOTH IN VITRO AND IN VIVO SYSTEMS | |
| CN103520171B (zh) | Kadcoccitones A在制备治疗肾综合征出血热药物中的应用 | |
| Shkurupy et al. | Experimental study of the efficiency of oxidized dextran for prevention of influenza A/H5N1 | |
| Wang et al. | Anti HIV-1 agents 6. synthesis and anti-HIV-1 activity of indolyl glyoxamides |